BARROW ROBERT (Chief Executive Officer) sold 1.3% of their position (19.02K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $721.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/5/2026ACC: 0001193125-26-384042
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+20.98K
Net shares
Net buyer
$721.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
40K acquired · 19.02K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+40K
Price / share
—
Trade value
—
% of position
2.7%
9/2/2026
1.47M→1.51M
Common Shares
Direct
Shares
−19.02K
Price / share
$37.94
Trade value
$721.73K
% of position
1.3%
9/3/2026
1.51M→1.49M
Total
Net shares
+20.98K
Net value
-$721.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/2/2026 | A · Award | +40K | — | — | 2.7% | 1.47M | 1.51M |
| Common Shares Direct | 9/3/2026 | S · Sale | −19.02K | $37.94 | $721.73K | 1.3% | 1.51M | 1.49M |
| Total | +20.98K | -$721.73K | ||||||
Derivative Transactions0
No derivative transactions reported